# Production of eCD4-IG protein

> **NIH NIH N01** · ADVANCED BIOSCIENCE LABORATORIES, INC. · 2021 · $955,917

## Abstract

This contract will provide NIAID with a broad and flexible range of nontraditional, proactive and developmentally-oriented capabilities to provide preclinical development for promising products for when such products emerge from investigator-initiated research studies. These capabilities will allow NIAID to more rapidly and efficiently close development and production gaps. Activities will include but not limited to small-scale production, preclinical testing and documentation leading to Investigational New Drug (IND) submission for Phase I, II, and III clinical testing.

## Key facts

- **NIH application ID:** 10329661
- **Project number:** 272201100021I-P00006-27200029-1
- **Recipient organization:** ADVANCED BIOSCIENCE LABORATORIES, INC.
- **Principal Investigator:** TIMOTHY FOUTS
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $955,917
- **Award type:** —
- **Project period:** 2015-09-18 → 2022-12-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10329661

## Citation

> US National Institutes of Health, RePORTER application 10329661, Production of eCD4-IG protein (272201100021I-P00006-27200029-1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10329661. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*